In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics.
about
Tachykinin neurokinin 3 receptor antagonists: a patent review (2005 - 2010).Progress in the development of neurokinin 3 modulators for the treatment of schizophrenia: molecule development and clinical progress.Population Pharmacokinetic and Pharmacodynamic Modeling of AZD4901 and Simulation to Support Dose Selection for the Phase 2a Study.
P2860
In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
In vitro and in vivo compariso ...... armacological characteristics.
@en
In vitro and in vivo compariso ...... armacological characteristics.
@nl
type
label
In vitro and in vivo compariso ...... armacological characteristics.
@en
In vitro and in vivo compariso ...... armacological characteristics.
@nl
prefLabel
In vitro and in vivo compariso ...... armacological characteristics.
@en
In vitro and in vivo compariso ...... armacological characteristics.
@nl
P2093
P1476
In vitro and in vivo compariso ...... armacological characteristics.
@en
P2093
Adeshola Dada
Ceri H Davies
Christopher J Langmead
Declan N C Jones
Eric Southam
Gareth A Jones
Graham S Murkitt
Jane E Cluderay
Jeannette M Watson
Jim J Hagan
P304
P356
10.1016/J.EJPHAR.2009.10.054
P407
P577
2009-10-30T00:00:00Z